Chemours (Mexico) Insiders
| CC Stock | MXN 408.90 0.00 0.00% |
Chemours employs about 6.6 K people. The company is managed by 10 executives with a total tenure of roughly 23 years, averaging almost 2.0 years of service per executive, having 660.0 employees per reported executive. Break down of Chemours' management performance can provide insight into the company performance.
| Mark Newman President CFO, Senior Vice President |
| Edwin Sparks President President - Chemical Solutions |
Chemours |
Chemours Management Team Effectiveness
The company has return on total asset (ROA) of 0.0653 % which means that it generated a profit of $0.0653 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.5281 %, meaning that it generated $0.5281 on every $100 dollars invested by stockholders. Chemours' management efficiency ratios could be used to measure how well Chemours manages its routine affairs as well as how well it operates its assets and liabilities.Chemours Workforce Comparison
The Chemours is number one stock in number of employees category among its peers. The total workforce of Specialty Chemicals industry is currently estimated at about 493,780. Chemours claims roughly 6,600 in number of employees contributing just under 2% to equities listed under Specialty Chemicals industry.
The company has Profit Margin (PM) of 0.09 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.12 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.12. Chemours Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Chemours Price Series Summation is a cross summation of Chemours price series and its benchmark/peer.
Chemours Notable Stakeholders
A Chemours stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Chemours often face trade-offs trying to please all of them. Chemours' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Chemours' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Mark Newman | CFO, Senior Vice President | Profile | |
| Edwin Sparks | President - Chemical Solutions | Profile | |
| Sameer Ralhan | CFO, Senior Vice President Treasurer | Profile | |
| Susan Kelliher | Senior Vice President – Human Resources and Health Services | Profile | |
| Alisha Bellezza | Director of Investor Relations | Profile | |
| Jonathan Lock | Sr Officer | Profile | |
| Kurt Bonner | Ma Relations | Profile | |
| Kristine Wellman | Gen VP | Profile | |
| Camela Wisel | Chief VP | Profile | |
| Alvenia Scarborough | Sr Officer | Profile |
About Chemours Management Performance
The success or failure of an entity such as Chemours often depends on how effective the management is. Chemours management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Chemours management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Chemours management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware. Chemours operates under Specialty Chemicals classification in Mexico and is traded on Mexico Stock Exchange. It employs 7000 people.
Please note, the imprecision that can be found in Chemours' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of The Chemours. Check Chemours' Beneish M Score to see the likelihood of Chemours' management manipulating its earnings.
Chemours Workforce Analysis
Traditionally, organizations such as Chemours use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Chemours within its industry.Chemours Manpower Efficiency
Return on Chemours Manpower
| Revenue Per Employee | 1M | |
| Revenue Per Executive | 679.4M | |
| Net Income Per Employee | 87.6K | |
| Net Income Per Executive | 57.8M |
Additional Tools for Chemours Stock Analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.